Air Global Misses Q3 2026 Estimates
Revenue of $99.8M vs. $101.0M expected and adjusted EPS of $0.05 vs. $0.06.
Air Global (AIIR) missed estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $99.8 million below the $101.0 million estimate, and adjusted EPS was $0.05 below the $0.06 estimate.
Shares rose 1.5% in regular trading as of 9:50 a.m. ET, at $7.69.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | $0.06 | $0.05 | Miss by 17% |
| Revenue | $101.0M | $99.8M | Miss by 1.2% |
| Change | QoQ |
|---|---|
| Adjusted EPS | ▲ from -$0.51 |
| Revenue | ▼ 26% |
By our calculation, revenue was $1.2 million below the estimate and adjusted EPS was $0.01 below it. The QoQ column compares with the previous quarter's revenue of $135.7 million and adjusted EPS of -$0.51.
Track record
- EPS record. Adjusted EPS beat the estimate in 0 of the last 2 reports, including this one.
- Revenue record. Revenue beat the estimate in 1 of the last 2 reports.
What to watch
- Next-quarter estimates. Consensus calls for EPS of $0.07 and revenue of $109.4 million next quarter, based on 1 analyst.
- Estimate record. Whether Air Global returns to beating EPS estimates, which it did in 0 of its last 2 reports.
- Share reaction. How shares trade in the next regular session after the 1.5% gain during the session.
- Related coverage. See our reports on Nebius, Parabilis Medicines, Hudbay Minerals and Accelerant.
Sources: Results are from Air Global's Nov. 12, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Air Global's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
Nebius Beats Q3 2026 Estimates as Revenue Rises 571% to $980.8M
EarningsParabilis Medicines Tops Q3 2026 Estimates
EarningsHudbay Minerals Q3 2026 Revenue Tops Estimates at $765.9M, but EPS Misses at $0.34
EarningsAccelerant Q3 2026 Revenue Tops Estimates at $280.2M, but EPS Misses at $0.18
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.
